James Campbell
Pediatric Infectious Diseases · Baltimore, MDNPI 1780627646
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,647 of the $3,522 with a category attached, or 75.1%. 3 manufacturers reported payments, led by Modernatx, Inc. at 38.4% of the total.
Across 21 payments — averaging $167.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$1K
- GSK$1K
- Merck$1K
Across 352 payments — averaging $5008.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$580K
- Modernatx, Inc.$550K
- GSK$344K
- Sanofi Pasteur Inc.$225K
- Merck$54K
- E.r. Squibb & Sons, L.L.C.$10K
What the payments were for
- Travel & lodging$2,64775%
- Food & beverage$87625%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 4 | $1,351 |
| GSK | 10 | $1,165 |
| Merck | 7 | $1,006 |
How this compares
Too few pediatric infectious diseases providers in Marylandto place this figure against a meaningful peer group, so we don't.
Other pediatric infectious diseases in Baltimore
- Nadia Sam-AguduBaltimore$12K
- Matthew LaurensBaltimore$2K
- Pranita TammaBaltimore$2K
- Nadine Peart AkindeleBaltimore$69
- Mark TravassosBaltimore$35
- Robert AnconaBaltimore$14
- Andrea BerryBaltimore$0
- Karen KotloffBaltimore$0
- Aaron MilstoneBaltimore$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.